Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer

Abstract Objective To assess the factors associated with the use of active surveillance (AS) in NCCN favourable intermediate‐risk (FIR) prostate cancer (PCa) patients who received the 17‐gene Genomic Prostate Score (GPS) assay. Material and Methods Contemporary data were collected from academic and...

Full description

Bibliographic Details

Published in:	BJUI Compass
Main Authors:	Eric Margolis, Benjamin H. Lowentritt, Christopher M. Pieczonka, John P. Bennett, Marina Pavlova, Joao Paulo Zambon, Jack Groskopf, Edward Uchio
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Subjects:	active surveillance biomarkers Favourable intermediate‐risk genomic testing prostate cancer
Online Access:	https://doi.org/10.1002/bco2.494